Sort
39,280 grants matching “leukemia”
Cellular and molecular analyses of hematopoietic stem cell [HSC] interactions with bone marrow niches to improve HSC engraftment for transplantation and tolerance induction
$374,965Irving Lerner Weissman · Stanford University · R01 · FY2020 · DK
Molecular Mechanism of Leukemogenesis involving AML1-ETO
$374,954Dong-Er Zhang · University Of California, San Diego · R01 · FY2021 · CA
HSC Diversity: Regulation by Clonal Selection vs Epigenetic Induction
$374,921Irving Lerner Weissman · Stanford University · R01 · FY2014 · CA
Cancer and Leukemia Group B - The Ohio State University
$374,894Clara D Bloomfield · Ohio State University · U10 · FY2006 · CA
A data-driven bioinformatics platform for the design and analysis of multiplexed antibody-based cytometry experiments in cancer research
$374,852Pablo Gonzalez Camara · University Of Pennsylvania · U01 · FY2023 · CA
Identification and characterization of genes in del(5q) myelodysplastic syndrome
$374,850Daniel Starczynowski · Cincinnati Childrens Hosp Med Ctr · R01 · FY2014 · HL
The Role of MEIS1 in Hematopoiesis and Hematopoietic Transformation
$374,850Ashish Kumar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2014 · HL
Dissecting the Functional Domains of Infected Cell Protein 0 of Herpes Simplex Virus 1
$374,834Haidong Gu · Wayne State University · R01 · FY2015 · AI
Linking IKKbeta activation to anti-autophagy in viral protein Tax-mediated oncoge
$374,829Hua Cheng · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2011 · AI
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen
$374,788Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
The impact of reduction of cellular senescence on age-related epigenetic heterogeneity
$374,770Sheng Li · University Of Southern California · U01 · FY2024 · CA
Project 2: Defining and exploiting genetic dependencies in complex karyotype AML
$374,760Scott W Lowe · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Project 3: Therapeutic inhibition of splicing through inhibition of protein arginine methylation in leukemia
$374,760Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Project 1: Increasing therapeutic efficacy in isocitrate dehydrongenase (IDH)âmutant acute myeloid leukemia (AML)
$374,760Ross L Levine · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Project 4: Chimeric Antigen Receptor T Cell Therapy for the Treatment of Acute Myeloid Leukemia
$374,759Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Effects of PGE2 on Reconstitution of Hematopoiesis and Immunity after UCBT
$374,707Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2015 · CA
Transgenesis and Xenotransplantation
$374,700Jorge A. Piedrahita · North Carolina State University Raleigh · R01 · FY2011 · HL
Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer
$374,645Peter A Cohen · Mayo Clinic Rochester · P50 · FY2014 · CA
Characterization of Erythropoiesis and Erythroid Cells.
$374,632Jeffery Miller · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Immunoglobulin and T Cell Receptor Gene Assembly
$374,625David G. Schatz · Yale University · R37 · FY2014 · AI
FUSION PROTEINS IN THE MOLECULAR PATHOGENESIS OF APL
$374,625Sloan-Kettering Institute For Cancer Res · R01 · FY2002 · CA
Immunoglobulin and T Cell Receptor Gene Assembly
$374,625David G. Schatz · Yale University · R37 · FY2015 · AI
FUSION PROTEINS IN THE MOLECULAR PATHOGENESIS OF APL
$374,625Sloan-Kettering Institute For Cancer Res · R01 · FY2001 · CA
FUSION PROTEINS IN THE MOLECULAR PATHOGENESIS OF APL
$374,625Sloan-Kettering Institute For Cancer Res · R01 · FY2000 · CA
FUSION PROTEINS IN THE MOLECULAR PATHOGENESIS OF APL
$374,625Sloan-Kettering Institute For Cancer Res · R01 · FY2004 · CA